Harry G M Heijerman

1. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
   2019/11/01 by Harry G M Heijerman, Edward F McKone, Edward F. McKone +87 · 3 citations
   Medicine · Social Sciences · #Cystic Fibrosis Research Advances #Delphi Technique in Research #Neonatal Respiratory Health Research